Inventor · disambiguated record
Adam Bucki
Also filed as: BUCKI ADAM
6 granted patents·3 pending applications·6 citations·filing 2011–2024
73Inventor score
Top patents by PatentIndex Score
9 records- 0187US11981668B2Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonistsADAMED PHARMA S A·Filed 2021·Granted May 14, 2024·2 cites·20 claims
- 0283US11034688B2Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonistsADAMED PHARMA S A·Filed 2019·Granted Jun 15, 2021·3 cites·20 claims
- 0378US12319682B2Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonistsADAMED PHARMA S A·Filed 2024·Granted Jun 3, 2025·0 cites·20 claims
- 0455US8822517B2Arylosulfonamides for the treatment of CNS diseasesKOLACZKOWSKI MARCIN·Filed 2011·Granted Sep 2, 2014·1 cites·13 claims
- 0547US10562853B2Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptorsNEUROLIXIS·Filed 2017·Granted Feb 18, 2020·0 cites·29 claims
- 0637US9120767B2Arylosulfonamides for the treatment of CNS diseasesKOŁACZKOWSKI MARCIN·Filed 2014·Granted Sep 1, 2015·0 cites·19 claims
- 0735US2015051257A1Sulphonamide derivatives of benzylamine for the treatment of cns diseasesADAMED SP ZOO·Filed 2013·Application pending·0 cites
- 0827US2014121216A1Indoleamine derivatives for the treatment of central nervous system diseasesKOLACZKOWSKI MARCIN·Filed 2012·Application pending·0 cites
- 0925US2014135310A1Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseasesKOLACZKOWSKI MARCIN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Bucki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →